{
    "laboratory_examinations": [
        {
            "procedure_name": "CSF biogenic amine metabolites",
            "date": "Not specified",
            "findings": {
                "5-Hydroxyindolacetic acid (5HIAA)": "146 nmol/L (Normal range: 66–141)",
                "5-Methyltetrahydrofolic acid (5MTHF)": "47.0 nmol/L (Normal range: 41–117)",
                "Neopterin (Neo)": "16.0 nmol/L (Normal range: 9–20)",
                "Biopterin (Bio)": "14.2 nmol/L (Normal range: 10–30)",
                "L-Dopa": "16.3 nmol/L",
                "3-O-methyl-Dopa (3OMD)": "886 nmol/L (Normal range: 150)",
                "Homovanillic acid (HVA)": "66 nmol/L (Normal range: 115–488)",
                "HVA/5HIAA ratio": "0.45 (Normal range: 1.5–3.5)"
            },
            "changes_over_time": "Significant reductions of the CSF HVA level and the HVA/5HIAA ratio suggested a TH deficiency."
        },
        {
            "procedure_name": "Mutation analysis of the TH gene",
            "date": "Not specified",
            "findings": "A compound heterozygous point mutation was found (1127C/H11022T in exon 10, 1493A/H11022G in exon 14).",
            "changes_over_time": "Not specified."
        }
    ]
}